Top 3 Techno News Today: Oppo Reno 4, Immunomodulator Covid-19

TEMPO.CO, Jakarta – Top 3 Tekno News today is occupied by an article about OPPO’s newest smartphone, viz OPPO Reno 4. Together with OPPO Watch, this phone is planned to be released Thursday, August 6, 2020 with features including the ability to hide messages or notifications only for cellphone owners.

The second article is a statement from an epidemiologist at the University of Indonesia about the opportunities for large cluster cases in public transportation in Jakarta. The third was about clinical trials for immunomodulatory candidates from native Indonesian herbal plants for Covid-19 patients at Wisma Atlet Hospital.

Here is the full Top 3 Techno today, Tuesday 4 April 2020,

1. Complete Specs OPPO Reno 4 and OPPO Watch to be released this week

OPPO Indonesia is holding a pre-launch for its two newest devices OPPO Reno 4 and OPPO Watch which will go on sale on Thursday, August 6, 2020. In the pre-launch on Monday, August 3, 2020, OPPO Indonesia’s PR Manager Aryo Meidianto presented the specifications of the two new devices.

In the event conducted through the video conference, Aryo claimed that OPPO Reno 4 will become a cell phone technology trendsetter this year. “In order to achieve this, OPPO Reno brings four aspects namely appearance, photography, technologi and the ColorOS operating system, “he said, Monday, August 3, 2020.

In terms of appearance, Aryo said, OPPO Reno 4 has a slimmer body with a thickness of 7.7 mm and a weight of 165 g, compared to OPPO Reno 3. So that this latest smartphone has better comfort when held when compared to its predecessor.

2. Epidemiologist: Cluster Penularan Covid-19 in Public Transportation Not Proven yet

EPidemiologist at the University of Indonesia (UI) Pandu Riono said there were no reports in the world about public transportation being a cluster of distribution Covid-19. “I just read in one of the foreign mass media that indeed they were worried the subway cluster would be high, but apparently not,” he said when contacted in Jakarta on Monday, August 3, 2020.

According to him, this is certainly inseparable from the application of health protocols that are truly stipulated in public transportation. So that even though there is a crowd or crowd, it has not become a cluster of corona virus spreads until now.

Pandu said the importance of applying health should also be properly understood and applied in Indonesia. Including, Pandu appointed Jakarta, which began on Monday to re-implement the even-odd transportation policy.

3. Clinical Trial Covid-19 LIPI Immunomodulator Is Targeted to be Completed on August 16

The research team at the Hospital Emergency Handling Covid-19 Wisma Atlet Kemayoran, Jakarta, successfully recruited the latest research subjects (90th subject) of which 72 of them had already completed the study clinical trial An immunomodulator candidate from a native Indonesian herbal plant for Covid-19 patients.

Clinical trial led by researchers from the Indonesian Institute of Sciences (LIPI) is targeted for completion on August 16, 2020.

Masteria Yunolvisa Putra from the LIPI Biotechnology Research Center as well as the Clinical Immunomodulatory Candidate Clinical Test Activity Coordinator for Handling Covid-19 explained the clinical trial method of immunomodulatory candidates conducted in a randomized, double-blind controlled placebo with placebo to protect against bias in research.

Share on facebook
Share on pinterest
Share on twitter
Share on linkedin
Share on email


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.